3D Cell Culture System Market By Technology ( Scaffold based, Bioreactors, Gels, Scaffold free platforms, Microchips ), By End-user ( Research laboratories, Biotechnology and pharmaceutical companies, Hospitals and diagnostics centers ), By Application ( Drug discovery, Research, Clinical applications, Tissue engineering, Stem cell biology ), Industry Trends, Estimation & Forecast, 2018 - 2025

  • Published On: Feb, 2019
  • Category: Healthcare
  • Pages: 174
3D Cell Culture Market is Anticipated to Reach a Value Of $3,534.5 Million By 2025 and Project a CAGR of 22.8% During the Forecast period 2018-2025.

Market Overview:

The global 3D cell culture market is experiencing a favorable growth trend as healthcare institutions, pharma companies, and research organizations have adopted 3D cell culture to get effective and affordable treatments for cancers. 3D cell culture offers an ideal environment for assessment of diseases at various stages with the help of cellular modelling. As 2D cell culture has faced certain limitations during this process, 3D technique provides an artificially created environment where cells interact with their surroundings in three-dimensions. This technique also has an ability to provide more physiologically relevant information and more predictive data for in-vivo tests. Such advantages offered by 3d cell culture makes it useful in wide range of applications such as disease pathology, drug discovery, organ transplantation, and tissue engineering. An increase in number of patients for organ transplantation, research activities, and number of efforts to avoid ethical concerns of animal usage are the major determinants boosting the growth of 3D cell culture market. In addition to this, different advantages offered by 3D cell culture over 2D cell culture such as better simulation of conditions in living organisms and more relevant cell models are other factors boosting the market. However, high initial investment required for implementing 3D cell culture may refrain small and medium sized pharma companies and laboratories from adopting 3D cell culture which would detain demand for the same during the forecast period. Use of 3D cell culture in stem cells and oncology offers different benefits which opens a pool of opportunities for anti-cancer therapeutics. The report provides detailed qualitative and quantitative analysis of the global 3D Cell Culture market. Market size and forecast in terms of value has been provided for the period - (2017 - 2025), for the segments namely technology, end-user, and application in each of the major regions of the world.

3D Cell Culture Market Segmentation

By Technology • Scaffold based • Bioreactors • Gels • Scaffold free platforms • Microchips By End-user • Research laboratories • Biotechnology and pharmaceutical companies • Hospitals and diagnostics centers • Others By Application • Drug discovery • Research • Clinical applications • Tissue engineering • Stem cell biology By Geography • North America o U.S. o Canada  • Europe o U.K o France o Germany o Rest of Europe • Asia-Pacific • Rest of the World o Middle East o Africa o South America

• 3D Biotek LLC.
• Kuraray Co.
• Merck & Co., Inc.
• Lonza Group
• Corning Incorporated
• Dickinson and Company
• Thermo Fisher Scientific Inc.
• Global Cell Solutions, Inc.
• Advanced Biomatrix, Inc.
• VWR International, LLC.

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS